Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2023-06-09 00:00:00 ET · period of report 2023-06-07 · accession 0001209191-23-036080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-06-09 | 2023-06-09 | KYNB | Brennan Aoife | Dir | S - Sale | $17.19 | -4,733 | 30.7K | -13% | -$81.4K |
| D | 2023-06-09 | 2023-06-07 | KYNB | Brennan Aoife | Dir | A - Grant | $0.00 | +8,289 | 32.7K | +34% | $0 |
| D | 2023-06-09 | 2023-06-07 | KYNB | Brennan Aoife | Dir | A - Grant | $0.00 | +12.7K | 12.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-09 | S | D | 2,739 | $17.52 | 27,947 | D | — | — | (F2) Represents the number of shares sold by the reporting person (pursuant to a 10b5-1 trading plan dated March 2, 2023) to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. (F4) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $17.26 to $17.72. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2023-06-09 | S | D | 1,994 | $16.74 | 30,686 | D | — | — | (F2) Represents the number of shares sold by the reporting person (pursuant to a 10b5-1 trading plan dated March 2, 2023) to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I. (F3) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $16.17 to $17.14. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2023-06-07 | A | A | 8,289 | $0.00 | 32,680 | D | — | — | (F1) Represents the grant of restricted stock units that vest on the earlier of June 7, 2024 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-06-07 | A | A | 12,666 | $0.00 | 12,666 | D | $17.13 · — to 2033-06-06 | 12,666 Common Stock | (F5) Options vest on the earlier of June 7, 2024 or the date of the next annual meeting of stockholders, subject to the reporting person's continuous service on the applicable vesting date. |